Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2024-05-03 | 2024-05-16 | 227037 |
PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-03-24 | 2017-04-07 | 4171 |
PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-07-25 | 2018-01-26 | 17024 |
PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2018-04-20 | 2019-02-26 | 46692 |
TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65346 |
SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-01-22 | 2020-08-17 | 73158 |
SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-01-22 | 2020-09-15 | 73161 |
SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2021-09-08 | 2022-12-12 | 145343 |
SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2021-09-08 | 2023-05-03 | 145346 |
SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2023-05-01 | 2023-05-09 | 191382 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |
RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
RAMIPRIL-HCTZ | 12.5MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3029 |
RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |